StockWatch
·

Kymera Therapeutics, Inc.

Ticker: 1815442

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-115.60-19.0677.49174.03Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26

Margin Trend

percentage
OPM %NPM %
-100.87-98.35-95.82-93.30Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26
PeriodQ2 FY26Q1 FY26Q3 FY25Q2 FY25Q1 FY25Q3 FY24Q2 FY24Q1 FY24
INCOME
Revenue65.00+89.1%34.37+1145.3%2.76-76.0%11.48-48.1%22.10+490.9%3.74-85.4%25.65+149.3%10.29
Total Income65.00+89.1%34.37+1145.3%2.76-76.0%11.48-48.1%22.10+490.9%3.74-85.4%25.65+149.3%10.29
EXPENSES
Expenditure140.61+18.6%118.52+24.4%95.29-0.8%96.03-0.5%96.53+27.2%75.87-0.9%76.58+12.4%68.12
PROFIT
Net Profit-61.21+11.6%-69.23+15.8%-82.18-7.3%-76.61-16.8%-65.58-4.9%-62.49-48.6%-42.06+13.4%-48.56
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-94.17%+5.83pp-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.62+12.7%-0.71+24.5%-0.94+1.1%-0.95-15.9%-0.82+0.0%-0.82-41.4%-0.58+15.9%-0.69

Corporate Events

Board MeetingKYMR
2026
27Jul

Board Meeting

Terence Rooney appointed Chief Medical Officer, succeeding J…

SEC Filing ↗
Board MeetingKYMR
2026
24Jun

Board Meeting

Annual Meeting of Shareholders to vote on the election of Cl…

SEC Filing ↗
Board MeetingKYMR
2026
24Jun

Board Meeting

Felix J. Baker appointed Chairman of the Board, succeeding B…

SEC Filing ↗
Board MeetingKYMR
2026
8Jun

Board Meeting

Leadership Changes — Penny Carlson appointed as Senior Vice …

SEC Filing ↗